Cell engineering with synthetic messenger RNA

Methods in Molecular Biology

Volumn 969, Issue , 2013, Pages 3-28

  Rabinovich, Peter M ^a   Weissman, Sherman M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adoptive immunotherapy; Cell reprogramming; Chimeric antigen receptor; Expression; MRNA; Review; RNA viruses; T cells; Transfection; Vaccination

Indexed keywords

MESSENGER RNA; POLYADENYLIC ACID BINDING PROTEIN; RNA; RNA BINDING PROTEIN; SYNTHETIC RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL ENGINEERING; CYTOPLASM; CYTOTOXIC T LYMPHOCYTE; ELECTROPORATION; GENE EXPRESSION; GENE LOCATION; GENE TARGETING; GENETIC CODE; GENETIC ENGINEERING; GENETIC STABILITY; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RNA TRANSLATION; VACCINATION; VIRUS PARTICLE; ANIMAL; BIOSYNTHESIS; CD8+ T LYMPHOCYTE; CELL DEDIFFERENTIATION; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; REVIEW;

ANIMALS; ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL DEDIFFERENTIATION; CELL ENGINEERING; GENE EXPRESSION REGULATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; RNA, MESSENGER;

MLCS; MLOWN;

EID: 84878641982     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-260-5_1     Document Type: Article

References (191)

1. Noguchi H, Matsushita M, Kobayashi N, Levy MF, Matsumoto S (2010) Recent advances in protein transduction technology. Cell Transplant 19(6):649-654
2. Grdisa M (2011) The delivery of biologically active (therapeutic) peptides and proteins into cells. Curr Med Chem 18(9):1373-1379
3. Van Tendeloo VF, Ponsaerts P, Lardon F, Nijs G, Lenjou M, Van Broeckhoven C, Van Bockstaele DR, Berneman ZN (2001) Highly ef ficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98(1):49-56
4. Saeboe-Larssen S, Fossberg E, Gaudernack G (2002) mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT). J Immunol Methods 259(1-2):191-203
5. Rabinovich PM, Komarovskaya ME, Ye Z-J, Imai C, Campana D, Bahceci E, Weissman SM (2006) Synthetic messenger RNA as a tool for gene therapy. Hum Gene Ther 17(10):1027-1035
6. Tavernier G, Andries O, Demeester J, Sanders NN, De Smedt SC, Rejman J (2011) mRNA as gene therapeutic: how to control protein expression. J Control Release 150(3):238-247
7. Yamamoto A, Kormann M, Rosenecker J, Rudolph C (2009) Current prospects for mRNA gene delivery. Eur J Pharm Biopharm 71(3):484-489
8. Schott JW, Galla M, Godinho T, Baum C, Schambach A (2011) Viral and non-viral approaches for transient delivery of mRNA and proteins. Curr Gene Ther 11(5):382-398
9. Van Tendeloo VFI, Ponsaerts P, Berneman ZN (2007) mRNA-based gene transfer as a tool for gene and cell therapy. Curr Opin Mol Ther 9(5):423-431
10. Pascolo S (2008) Vaccination with messenger RNA. Handb Exp Pharmacol 183: 221-235
11. Jackson RJ, Hellen CU, Pestova TV (2010) The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 11(2):113-127
12. Jackson RJ, Hellen CU, Pestova TV (2012) Termination and post-termination events in eukaryotic translation. Adv Protein Chem Struct Biol 86:45-93
13. Sonenberg N, Hinnebusch AG (2009) Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136(4):731-745
14. Boczkowski D, Nair S (2010) RNA as performance-enhancers for dendritic cells. Expert Opin Biol Ther 10(4):563-574
15. Dikstein R (2012) Transcription and translation in a package deal: the TISU paradigm. Gene 491(1):1-4
16. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9(2):102-114
17. Cheneval D, Kastelic T, Fuerst P, Parker CN (2010) A review of methods to monitor the modulation of mRNA stability: a novel approach to drug discovery and therapeutic intervention. J Biomol Screen 15(6):609-622. doi:10.1177/1087057110365897
18. Glisovic T, Bachorik JL, Yong J, Dreyfuss G (2008) RNA-binding proteins and posttranscriptional gene regulation. FEBS Lett 582(14):1977-1986
19. Idler RK, Yan W (2012) Control of messenger RNA fate by RNA binding proteins: an emphasis on mammalian spermatogenesis. J Androl 33(3):309-337
20. Macdonald PM (2011) mRNA localization: assembly of transport complexes and their incorporation into particles. Curr Opin Genet Dev 21(4):407-413
21. Palazzo AF, Akef A (2012) Nuclear export as a key arbiter of "mRNA identity" in eukaryotes. Biochim Biophys Acta 1819(6):566-577
22. Nojima T, Hirose T, Kimura H, Hagiwara M (2007) The interaction between cap-binding complex and RNA export factor is required for intronless mRNA export. J Biol Chem 282(21):15645-15651
23. Maquat LE, Tarn WY, Isken O (2010) The pioneer round of translation: features and functions. Cell 142(3):368-374
24. Apcher S, Manoury B, Fahraeus R (2012) The role of mRNA translation in direct MHC class I antigen presentation. Curr Opin Immunol 24(1):71-76
25. Anderson P, Kedersha N (2009) RNA granules: post-transcriptional and epigenetic modulators of gene expression. Nat Rev Mol Cell Biol 10(6):430-436. doi:10.1038/nrm2694
26. Gingold H, Pilpel Y (2011) Determinants of translation ef ficiency and accuracy. Mol Syst Biol 7:481
27. Tsai CJ, Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM, Nussinov R (2008) Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima. J Mol Biol 383(2):281-291
28. Spriggs KA, Bushell M, Willis AE (2010) Translational regulation of gene expression during conditions of cell stress. Mol Cell 40(2):228-237
29. Steitz JA, Vasudevan S (2009) miRNPs: versatile regulators of gene expression in vertebrate cells. Biochem Soc Trans 37(Pt 5):931-935. doi:10.1042/BST0370931
30. Wilkie GS, Dickson KS, Gray NK (2003) Regulation of mRNA translation by 5 ¢ -and 3 ¢ -UTR-binding factors. Trends Biochem Sci 28(4):182-188
31. Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318(5858):1931-1934
32. Lee EK, Gorospe M (2011) Coding region: the neglected post-transcriptional code. RNA Biol 8(1):44-48
33. Schoenberg DR, Maquat LE (2009) Re-capping the message. Trends Biochem Sci 34(9):435-442
34. Sachs ABVG (2000) Eukaryotic translation initiation. Nat Struct Biol 7(5):356-361
35. Svitkin YV, Sonenberg N (2006) Translational control by the poly(A) binding protein: a check for mRNA integrity. Mol Biol 40(4):611-619
36. Wang XQRJ (2004) 5 untranslated regions with multiple upstream AUG codons can support low-level translation via leaky scanning and reinitiation. Nucleic Acids Res 32(4):1382-1391
37. Leipuviene R, Theil EC (2007) The family of iron responsive RNA structures regulated by changes in cellular iron and oxygen. Cell Mol Life Sci 64(22):2945-2955
38. Hamilton TL, Stoneley M, Spriggs KA, Bushell M (2006) TOPs and their regulation. Biochem Soc Trans 34(1):12-16
39. Kozak M (2005) Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 361:13-37
40. Elfakess R, Sinvani H, Haimov O, Svitkin Y, Sonenberg N, Dikstein R (2011) Unique translation initiation of mRNAs-containing TISU element. Nucleic Acids Res 39(17):7598-7609
41. Kieft JS (2008) Viral IRES RNA structures and ribosome interactions. Trends Biochem Sci 33(6):274-283
42. Komar AA, Hatzoglou M (2011) Cellular IRES-mediated translation: the war of ITAFs in pathophysiological states. Cell Cycle 10(2):229-240
43. Gilbert WV (2010) Alternative ways to think about cellular internal ribosome entry. J Biol Chem 285(38):29033-29038
44. Thakor N, Holcik M (2012) IRES-mediated translation of cellular messenger RNA operates in eIF2alpha-independent manner during stress. Nucleic Acids Res 40(2):541-552
45. Bono F, Gehring NH (2011) Assembly, disassembly and recycling: the dynamics of exon junction complexes. RNA Biol 8(1):24-29
46. Maquat LE (2004) Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 5(2):89-99
47. Nott A, Le Hir H, Moore MJ (2004) Splicing enhances translation in mammalian cells: an additional function of the exon junction complex. Genes Dev 18(2):210-222
48. Kuersten S, Goodwin EB (2003) The power of the 3 ¢ UTR: translational control and development. Nat Rev Genet 4(8):626-637
49. Arava Y (2009) Compaction of polyribosomal mRNA. RNA Biol 6(4):399-401
50. Mazumder B, Seshadri V, Fox PL (2003) Translational control by the 3 ¢ -UTR: the ends specify the means. Trends Biochem Sci 28(2):91-98
51. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, Clawson H, Spieth J, Hillier LW, Richards S, Weinstock GM, Wilson RK, Gibbs RA, Kent WJ, Miller W, Haussler D (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15(8):1034-1050
52. Mignone F, Gissi C, Liuni S, Pesole G (2002) Untranslated regions of mRNAs. Genome Biol 3 (3):REVIEWS0004
53. Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351-379
54. Mercer TR, Wilhelm D, Dinger ME, Solda G, Korbie DJ, Glazov EA, Truong V, Schwenke M, Simons C, Matthaei KI, Saint R, Koopman P, Mattick JS (2011) Expression of distinct RNAs from 3 ¢ untranslated regions. Nucleic Acids Res 39(6):2393-2403
55. Jeyapalan Z, Yang BB (2012) The non-coding 3 ¢ UTR of CD44 induces metastasis by regulating extracellular matrix functions. J Cell Sci
56. Kuhn U, Gundel M, Knoth A, Kerwitz Y, Rudel S, Wahle E (2009) Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation speci ficity factor. J Biol Chem 284(34):22803-22814
57. Gray NKCJ, Dickson KS, Wickens M (2000) Multiple portions of poly(A)-binding protein stimulate translation in vivo. EMBO J 19(17):4723-4733
58. Marzluff WF, Wagner EJ, Duronio RJ (2008) Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat Rev Genet 9(11):843-854
59. Martin KC, Ephrussi A (2009) mRNA localization: gene expression in the spatial dimension. Cell 136(4):719-730
60. Chabanon H, Nury D, Mickleburgh I, Burtle B, Hesketh J (2004) Characterization of the cis-acting element directing perinuclear localization of the metallothionein-1 mRNA. Biochem Soc Trans 32(Pt 5):702-704
61. Andreassi C, Riccio A (2009) To localize or not to localize: mRNA fate is in 3 ¢ UTR ends. Trends Cell Biol 19(9):465-474
62. Thio GL, Ray RP, Barcelo G, Schupbach T (2000) Localization of gurken RNA in Drosophila oogenesis requires elements in the 5 ¢ and 3 ¢ regions of the transcript. Dev Biol 221(2):435-446
63. Chartrand P, Meng XH, Singer RH, Long RM (1999) Structural elements required for the localization of ASH1 mRNA and of a green fl uorescent protein reporter particle in vivo. Current biology 9(6):333-336
64. Hachet O, Ephrussi A (2004) Splicing of oskar RNA in the nucleus is coupled to its cytoplasmic localization. Nature 428(6986):959-963
65. Shahbabian K, Chartrand P (2012) Control of cytoplasmic mRNA localization. Cell Mol Life Sci 69(4):535-552
66. Donnelly CJ, Fainzilber M, Twiss JL (2010) Subcellular communication through RNA transport and localized protein synthesis. Traf fic 11(12):1498-1505
67. Besse F, Ephrussi A (2008) Translational control of localized mRNAs: restricting protein synthesis in space and time. Nat Rev Mol Cell Biol 9(12):971-980
68. Chen Q, Jagannathan S, Reid DW, Zheng T, Nicchitta CV (2011) Hierarchical regulation of mRNA partitioning between the cytoplasm and the endoplasmic reticulum of mammalian cells. Mol Biol Cell 22(14):2646-2658
69. Janda CY, Li J, Oubridge C, Hernandez H, Robinson CV, Nagai K (2010) Recognition of a signal peptide by the signal recognition particle. Nature 465(7297):507-510
70. Pyhtila B, Zheng T, Lager PJ, Keene JD, Reedy MC, Nicchitta CV (2008) Signal sequence-and translation-independent mRNA localization to the endoplasmic reticulum. RNA 14(3):445-453
71. Buchan JR, Parker R (2009) Eukaryotic stress granules: the ins and outs of translation. Mol Cell 36(6):932-941
72. Fawal M, Jean-Jean O, Vanzo N, Morello D (2011) Novel mRNA-containing cytoplasmic granules in ALK-transformed cells. Mol Biol Cell 22(6):726-735
73. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M (2011) Global quanti fication of mammalian gene expression control. Nature 473(7347):337-342
74. Peixeiro I, Silva AL, Romao L (2011) Control of human beta-globin mRNA stability and its impact on beta-thalassemia phenotype. Haematologica 96(6):905-913
75. Balagopal V, Fluch L, Nissan T (2012) Ways and means of eukaryotic mRNA decay. Biochim Biophys Acta 1819(6):593-603
76. Ji X, Liebhaber SA (2007) mRNA stability and the control of gene expression 77. Wiederhold K, Passmore LA (2010) Cytoplasmic deadenylation: regulation of mRNA fate. Biochem Soc Trans 38(6):1531-1536
77. Amrani N, Ghosh S, Mangus DA, Jacobson A (2008) Translation factors promote the formation of two states of the closed-loop mRNP. Nature 453(7199):1276-1280
78. Stalder L, Muhlemann O (2009) Processing bodies are not required for mammalian nonsense-mediated mRNA decay. RNA 15(7):1265-1273
79. Belasco JG (2010) All things must pass: contrasts and commonalities in eukaryotic and bacterial mRNA decay. Nat Rev Mol Cell Biol 11(7):467-478
80. Gong C, Maquat LE (2011) lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3 UTRs via Alu elements. Nature 470(7333):284-288
81. Czech B, Hannon GJ (2011) Small RNA sorting: matchmaking for Argonautes. Nat Rev Genet 12(1):19-31
82. Sawicka K, Bushell M, Spriggs KA, Willis AE (2008) Polypyrimidine-tract- binding protein: a multifunctional RNA-binding protein. Biochem Soc Trans 36(Pt 4):641-647
83. Adeli K (2011) Translational control mechanisms in metabolic regulation: critical role of RNA binding proteins, microRNAs, and cytoplasmic RNA granules. Am J Physiol Endocrinol Metab 301(6):E1051-E1064
84. Wang KC, Chang HY (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43(6):904-914. doi: 10.1016/j. molcel.2011.08.018
85. Tuck AC, Tollervey D (2011) RNA in pieces. Trends Genet 27(10):422-432
86. Grudzien-Nogalska E, Jemielity J, Kowalska J, Darzynkiewicz E, Rhoads RE (2007) Phosphorothioate cap analogs stabilize mRNA and increase translational ef ficiency in mammalian cells. RNA 13(10):1745-1755
87. Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, Tureci O, Sahin U (2006) Modi fication of antigen-encoding RNA increases stability, translational ef ficacy, and T-cell stimulatory capacity of dendritic cells. Blood 108(13):4009-4017
88. Hayashi T, Lamba DA, Slowik A, Reh TA, Bermingham-McDonogh O (2010) A method for stabilizing RNA for transfection that allows control of expression duration. Dev Dyn 239(7):2034-2040
89. Parker R, Song H (2004) The enzymes and control of eukaryotic mRNA turnover. Nat Struct Mol Biol 11(2):121-127. doi:10.1038/nsmb724
90. Otsuka Y, Kedersha NL, Schoenberg DR (2009) Identi fication of a cytoplasmic complex that adds a cap onto 5 -monophosphate RNA. Mol Cell Biol 29(8):2155-2167
91. Novoa I, Gallego J, Ferreira PG, Mendez R (2010) Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control. Nat Cell Biol 12(5): 447-456
92. Villalba A, Coll O, Gebauer F (2011) Cytoplasmic polyadenylation and translational control. Curr Opin Genet Dev 21(4): 452-457
93. Shalem O, Dahan O, Levo M, Martinez MR, Furman I, Segal E, Pilpel Y (2008) Transient transcriptional responses to stress are generated by opposing effects of mRNA production and degradation. Mol Syst Biol 4:223
94. Ma S, Bhattacharjee RB, Bag J (2009) Expression of poly(A)-binding protein is upregulated during recovery from heat shock in HeLa cells. FEBS J 276(2):552-570
95. de Nadal E, Ammerer G, Posas F (2011) Controlling gene expression in response to stress. Nat Rev Genet 12(12):833-845
96. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247(4949 Pt 1):1465-1468
97. Probst JWB, Scheel B, Pichler BJ, Hoerr I, Rammensee HG, Pascolo S (2007) Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-speci fic, saturable and ion dependent. Gene Ther 14(15):1175-1180
98. Diken M, Kreiter S, Selmi A, Britten CM, Huber C, Tureci O, Sahin U (2011) Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation. Gene Ther 18(7):702-708
99. Lorenz C, Fotin-Mleczek M, Roth G, Becker C, Dam TC, Verdurmen WP, Brock R, Probst J, Schlake T (2011) Protein expression from exogenous mRNA: uptake by receptormediated endocytosis and traf ficking via the lysosomal pathway. RNA Biol 8(4):627-636
100. Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, Homey B, Barrat FJ, Zal T, Gilliet M (2009) Self-RNAantimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 206(9):1983-1994
101. Pascolo S (2011) Commenting on communicator RNA. Gene Ther 18(10):943-944
102. Mir LM (2009) Nucleic acids electrotransferbased gene therapy (electrogenetherapy): past, current, and future. Mol Biotechnol 43(2):167-176. doi:10.1007/s12033-009-9192-6
103. Faurie C, Rebersek M, Golzio M, Kanduser M, Escoffre JM, Pavlin M, Teissie J, Miklavcic D, Rols MP (2010) Electro-mediated gene transfer and expression are controlled by the life-time of DNA/membrane complex formation. J Gene Med 12(1):117-125. doi:10.1002/jgm.1414
104. Satkauskas S, Bureau MF, Puc M, Mahfoudi A, Scherman D, Miklavcic D, Mir LM (2002) Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. Mol Ther 5(2):133-140. doi:10.1006/mthe.2002.0526
105. Geng T, Zhan Y, Wang J, Lu C (2011) Transfection of cells using fl ow-through electroporation based on constant voltage. Nat Protoc 6(8):1192-1208. doi:10.1038/nprot.2011.360
106. Kim JA, Cho K, Shin MS, Lee WG, Jung N, Chung C, Chang JK (2008) A novel electroporation method using a capillary and wire-type electrode. Biosens Bioelectron 23(9):1353-1360
107. Li L, Liu LN, Feller S, Allen C, Shivakumar R, Fratantoni J, Wolfraim LA, Fujisaki H, Campana D, Chopas N, Dzekunov S, Peshwa M (2010) Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method. Cancer Gene Ther 17(3):147-154
108. Choi Y, Yuen C, Maiti SN, Olivares S, Gibbons H, Huls H, Raphael R, Killian TC, Stark DJ, Lee DA, Torikai H, Monticello D, Kelly SS, Kebriaei P, Champlin RE, Biswal SL, Cooper LJ (2010) A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the speci ficity of human T cells. Biomed Microdevices 12(5):855-863
109. Johnson BDGJ, Gershan J, Natalia N, Zujewski H, Weber JJ, Yan X, Orentas RJ (2005) Neuroblastoma cells transiently transfected to simultaneously express the co-stimulatory molecules CD54, CD80, CD86, and CD137L generate antitumor immunity in mice. J Immunother 28(5):449-460
110. Amaxa-Lonza (2012) Nucleofection technology. http://www.lonza.com/ products-services/bio-research/transfection/nucleofector-technology. aspx
111. Gresch O, Altrogge L (2012) Transfection of dif ficult-to-transfect primary mammalian cells. Methods Mol Biol 801:65-74
112. Su X, Fricke J, Kavanagh DG, Irvine DJ (2011) In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles. Mol Pharm 8(3):774-787
113. Akinc A, Thomas M, Klibanov AM, Langer R (2005) Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 7(5):657-663
114. Troiber C, Wagner E (2011) Nucleic acid carriers based on precise polymer conjugates. Bioconjug Chem 22(9):1737-1752
115. Boe S, Saeboe-Larssen S, Hovig E (2010) Light-induced gene expression using messenger RNA molecules. Oligonucleotides 20(1):1-6
116. Perche F, Benvegnu T, Berchel M, Lebegue L, Pichon C, Jaffres P-A, Midoux P (2011) Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA. Nanomedicine 7(4):445-453
117. Zou S, Scarfo K, Nantz MH, Hecker JG (2010) Lipid-mediated delivery of RNA is more ef ficient than delivery of DNA in non-dividing cells. Int J Pharm 389(1-2):232-243
118. Walch B, Breinig T, Schmitt MJ, Breinig F (2012) Delivery of functional DNA and messenger RNA to mammalian phagocytic cells by recombinant yeast. Gene Ther 19(3):237-245
119. Stiles KM, Kielian M (2011) Alphavirus entry: NRAMP leads the way. Cell Host Microbe 10(2):92-93
120. Ehrengruber MU, Schlesinger S, Lundstrom K (2011) Alphaviruses: Semliki forest virus and Sindbis virus vectors for gene transfer into neurons. Curr Protoc Neurosci Chapter 4:Unit 4.22
121. Lundstrom K (2009) Alphaviruses in gene therapy. Viruses 1(1):13-25
122. Haywood AM (2010) Membrane uncoating of intact enveloped viruses. J Virol 84(21):10946-10955
123. Bitzer M, Armeanu S, Lauer UM, Neubert WJ (2003) Sendai virus vectors as an emerging negative-strand RNA viral vector system. J Gene Med 5(7):543-553
124. Kinoh H, Inoue M (2008) New cancer therapy using genetically-engineered oncolytic Sendai virus vector. Front Biosci 13:2327-2334
125. Nishimura K, Sano M, Ohtaka M, Furuta B, Umemura Y, Nakajima Y, Ikehara Y, Kobayashi T, Segawa H, Takayasu S, Sato H, Motomura K, Uchida E, Kanayasu-Toyoda T, Asashima M, Nakauchi H, Yamaguchi T, Nakanishi M (2010) Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem 286(6):4760-4771
126. Kaneda Y (2011) HVJ liposomes and HVJ envelope vectors. Cold Spring Harb Protoc 2011(10):1281-1289
127. Galla M, Schambach A, Falk CS, Maetzig T, Kuehle J, Lange K, Zychlinski D, Heinz N, Brugman MH, Gohring G, Izsvak Z, Ivics Z, Baum C (2011) Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery. Nucleic Acids Res 39(16):7147-7160
128. Kariko K, Buckstein M, Ni H, Weissman D (2005) Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modi fication and the evolutionary origin of RNA. Immunity 23(2):165-175
129. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ (2010) Highly ef ficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modi fied mRNA. Cell Stem Cell 7(5):618-630
130. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann K-K, Schlee M, Endres S, Hartmann G (2006) 5 ¢ -Triphosphate RNA is the ligand for RIG-I. Science 314(5801):994-997
131. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C (2006) RIG-I-mediated antiviral responses to singlestranded RNA bearing 5 ¢ -phosphates. Science 314(5801):997-1001
132. Onoguchi K, Yoneyama M, Fujita T (2011) Retinoic acid-inducible gene-I-like receptors. J Interferon Cytokine Res 31(1):27-31
133. Kawai T, Akira S (2006) Innate immune recognition of viral infection. Nat Immunol 7(2):131-137
134. Honda K, Taniguchi T (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6(9):644-658
135. Angel MYM (2010) Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One 5(7):e11756
136. Pindel A, Sadler A (2011) The role of protein kinase R in the interferon response. J Interferon Cytokine Res 31(1):59-70
137. Nallagatla SRTR, Toroney R, Bevilacqua PC (2008) A brilliant disguise for self RNA: 5 ¢ -end and internal modi fications of primary transcripts suppress elements of innate immunity. RNA Biol 5(3):140-144
138. Kariko K, Muramatsu H, Ludwig J, Weissman D (2011) Generating the optimal mRNA for therapy: HPLC puri fication eliminates immune activation and improves translation of nucleoside-modi fied, protein-encoding mRNA. Nucleic Acids Res 39(21):e142. doi:10.1093/nar/gkr695
139. Anderson BR, Muramatsu H, Nallagatla SR, Bevilacqua PC, Sansing LH, Weissman D, Kariko K (2010) Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res 38(17):5884-5892
140. Koski GKKK, Xu S, Weissman D, Cohen PA, Czerniecki BJ (2004) Cutting edge innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J Immunol 172(7):3989-3993
141. Kormann MS, Hasenpusch G, Aneja MK, Nica G, Flemmer AW, Herber-Jonat S, Huppmann M, Mays LE, Illenyi M, Schams A, Griese M, Bittmann I, Handgretinger R, Hartl D, Rosenecker J, Rudolph C (2011) Expression of therapeutic proteins after delivery of chemically modi fied mRNA in mice. Nat Biotechnol 29(2):154-157. doi:10.1038/nbt.1733
142. Weide B, Carralot JP, Reese A, Scheel B, Eigentler TK, Hoerr I, Rammensee HG, Garbe C, Pascolo S (2008) Results of the first phase I/II clinical vaccination trial with direct injection of mRNA. J Immunother 31(2):180-188
143. Kreiter S, Diken M, Selmi A, Tureci O, Sahin U (2011) Tumor vaccination using messenger RNA: prospects of a future therapy. Curr Opin Immunol 23(3):399-406
144. Weiss R, Scheiblhofer S, Roesler E, Ferreira F, Thalhamer J (2010) Prophylactic mRNA vaccination against allergy. Curr Opin Allergy Clin Immunol 10(6):567-574
145. Bringmann A, Held SA, Heine A, Brossart P (2010) RNA vaccines in cancer treatment. J Biomed Biotechnol 2010:623687
146. Pascolo S (2006) Vaccination with messenger RNA. Methods Mol Med 127:23-40
147. Met O, Balslev E, Flyger H, Svane IM (2011) High immunogenic potential of p53 mRNAtransfected dendritic cells in patients with primary breast cancer. Breast Cancer Res Treat 125(2):395-406
148. Lee J, Dollins CM, Boczkowski D, Sullenger BA, Nair S (2008) Activated B cells modi fied by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-speci fic T-cell responses. Immunology 125(2):229-240
149. Van Camp K, Cools N, Stein B, Van de Velde A, Goossens H, Berneman ZN, Van Tendeloo V (2010) Ef ficient mRNA electroporation of peripheral blood mononuclear cells to detect memory T cell responses for immunomonitoring purposes. J Immunol Methods 354(1-2):1-10
150. Doucet J-D, Gauchat D, Lapointe R (2011) Identi fication of T-cell epitopes by a novel mRNA PCR-based epitope chase technique. J Immunother 34(2):183-186
151. Apcher S, Daskalogianni C, Lejeune F, Manoury B, Imhoos G, Heslop L, Fahraeus R (2011) Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation. Proc Natl Acad Sci USA 108(28):11572-11577
152. Neefjes J, Jongsma ML, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11(12):823-836
153. Basha G, Omilusik K, Chavez-Steenbock A, Reinicke AT, Lack N, Choi KB, Jefferies WA (2012) A CD74-dependent MHC class I endolysosomal cross-presentation pathway. Nat Immunol 13(3):237-245
154. Rabinovich PM, Komarovskaya ME, Wrzesinski SH, Alderman JL, Budak-Alpdogan T, Karpikov A, Guo H, Flavell RA, Cheung N-K, Weissman SM, Bahceci E (2009) Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytes. Hum Gene Ther 20(1):51-61
155. Yoon SH, Lee JM, Cho HI, Kim EK, Kim HS, Park MY, Kim TG (2009) Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-speci fic chimeric immune receptor in ovarian cancer xenograft model. Cancer Gene Ther 16(6):489-497
156. Zhao YB, Zheng ZL, Cohen CJ, Gattinoni L, Palmer DC, Restifo NP, Rosenberg SA, Morgan RA (2006) High-ef ficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol Ther 13(1):151-159
157. Mitchell DA, Karikari I, Cui X, Xie W, Schmittling R, Sampson JH (2008) Selective modi fication of antigen-speci fic T cells by RNA electroporation. Hum Gene Ther 19(5):511-521
158. Rowley J, Monie A, Hung CF, Wu TC (2009) Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8+ T cells modi fies adoptively transferred T-cell function in cis. Eur J Immunol 39(2):491-506
159. Hawkins RE, Gilham DE, Debets R, Eshhar Z, Taylor N, Abken H, Schumacher TN, ATTACK Consortium (2010) Development of adoptive cell therapy for cancer: a clinical perspective. Hum Gene Ther 21(6):665-672
160. Zhang L, Morgan RA (2011) Genetic engineering with T cell receptors. Adv Drug Deliv Rev 64(8):756-762
161. Kershaw MH, Teng MW, Smyth MJ, Darcy PK (2005) Supernatural T cells: genetic modi fication of T cells for cancer therapy. Nat Rev Immunol 5(12):928-940
162. Eshhar Z (2010) Adoptive cancer immunotherapy using genetically engineered designer T-cells: first steps into the clinic. Curr Opin Mol Ther 12(1):55-63
163. Kaneko S, Mastaglio S, Bondanza A, Ponzoni M, Sanvito F, Aldrighetti L, Radrizzani M, La Seta-Catamancio S, Provasi E, Mondino A, Nagasawa T, Fleischhauer K, Russo V, Traversari C, Ciceri F, Bordignon C, Bonini C (2009) IL-7 and IL-15 allow the generation of suicide gene-modi fied alloreactive self-renewing central memory human T lymphocytes. Blood 113(5):1006-1015
164. Hoyos V, Savoldo B, Quintarelli C, Mahendravada A, Zhang M, Vera J, Heslop HE, Rooney CM, Brenner MK, Dotti G (2010) Engineering CD19-speci fic T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety. Leukemia 24(6): 1160-1170
165. Almasbak H, Lundby M, Rasmussen AM (2010) Non-MHC-dependent redirected T cells against tumor cells. Methods Mol Biol 629:453-493
166. Barrett DM, Zhao Y, Liu X, Jiang S, Carpenito C, Kalos M, Carroll RG, June CH, Grupp SA (2011) Treatment of advanced leukemia in mice with mRNA engineered T cells. Hum Gene Ther 22(12):1575-1586
167. Yoon SH, Lee JM, Cho HI, Kim EK, Kim HS, Park MY, Kim TG (2009) Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-speci fic chimeric immune receptor in ovarian cancer xenograft model. Cancer Gene Ther 16(6):489-497
168. Zhao Y, Moon E, Carpenito C, Paulos CM, Liu X, Brennan AL, Chew A, Carroll RG, Scholler J, Levine BL, Albelda SM, June CH (2010) Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. Cancer Res 70(22): 9053-9061
169. Birkholz K, Hombach A, Krug C, Reuter S, Kershaw M, Kampgen E, Schuler G, Abken H, Schaft N, Dorrie J (2009) Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer. Gene Ther 16(5):596-604
170. Yoon SH, Lee JM, Woo SJ, Park MJ, Park JS, Kim HS, Park MY, Sohn HJ, Kim TG (2009) Transfer of Her-2/neu speci ficity into cytokine-induced killer (CIK) cells with RNA encoding chimeric immune receptor (CIR). J Clin Immunol 29(6):806-814
171. Boissel L, Betancur M, Wels WS, Tuncer H, Klingemann H (2009) Transfection with mRNA for CD19 speci fic chimeric antigen receptor restores NK cell mediated killing of CLL cells. Leuk Res 33(9):1255-1259
172. Boissel L, Betancur M, Lu W, Wels WS, Marino T, Van Etten RA, Klingemann H (2012) Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens. Leuk Lymphoma 53(5):958-965
173. Marin V, Dander E, Biagi E, Introna M, Fazio G, Biondi A, D Amico G (2006) Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy. Exp Hematol 34(9):1219-1229
174. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by de fined factors. Cell 131(5):861-872
175. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by de fined factors. Cell 126(4):663-676
176. Yakubov E, Rechavi G, Rozenblatt S, Givol D (2010) Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem Bioph Res Commun 394(1):189-193
177. Plews JR, Li JL, Jones M, Moore HD, Mason C, Andrews PW, Na J (2010) Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach. PLoS One 5(12):e14397
178. Walia B, Satija N, Tripathi RP, Gangenahalli GU (2012) Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its rami fications on regenerative medicine. Stem Cell Rev 8(1):100-115
179. Carroll D (2011) Genome engineering with zinc-finger nucleases. Genetics 188(4):773-782. doi:10.1534/genetics.111.131433
180. Segal DJ (2011) Zinc-finger nucleases transition to the CoDA. Nat Methods 8(1):53-55. doi:10.1038/nmeth0111-53
181. Carlson DF, Fahrenkrug SC, Hackett PB (2012) Targeting DNA with fingers and TALENs. Mol Ther Nucleic Acids 1 (1):e3. doi:10.1038/mtna.2011.5
182. Hockemeyer D, Wang H, Kiani S, Lai CS, Gao Q, Cassady JP, Cost GJ, Zhang L, Santiago Y, Miller JC, Zeitler B, Cherone JM, Meng X, Hinkley SJ, Rebar EJ, Gregory PD, Urnov FD, Jaenisch R (2011) Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 29(8):731-734. doi:10.1038/nbt.1927
183. Flisikowska T, Thorey IS, Offner S, Ros F, Lifke V, Zeitler B, Rottmann O, Vincent A, Zhang L, Jenkins S, Niersbach H, Kind AJ, Gregory PD, Schnieke AE, Platzer J (2011) Ef ficient immunoglobulin gene disruption and targeted replacement in rabbit using zinc finger nucleases. PLoS One 6(6):e21045. doi:10.1371/journal.pone.0021045
184. Watanabe M, Umeyama K, Matsunari H, Takayanagi S, Haruyama E, Nakano K, Fujiwara T, Ikezawa Y, Nakauchi H, Nagashima H (2010) Knockout of exogenous EGFP gene in porcine somatic cells using zinc-finger nucleases. Biochem Bioph Res Commun 402(1):14-18. doi:10.1016/j.bbrc.2010.09.092
185. Doyon Y, McCammon JM, Miller JC, Faraji F, Ngo C, Katibah GE, Amora R, Hocking TD, Zhang L, Rebar EJ, Gregory PD, Urnov FD, Amacher SL (2008) Heritable targeted gene disruption in zebra fish using designed zinc-finger nucleases. Nat Biotechnol 26(6):702-708
186. Meng X, Noyes MB, Zhu LJ, Lawson ND, Wolfe SA (2008) Targeted gene inactivation in zebra fish using engineered zinc-finger nucleases. Nat Biotechnol 26(6):695-701. doi:10.1038/nbt1398
187. McCammon JM, Amacher SL (2010) Using zinc finger nucleases for ef ficient and heritable gene disruption in zebra fish. Methods Mol Biol 649:281-298. doi:10.1007/978-1-60761-753-2-18
188. Breaker RR (2011) Prospects for riboswitch discovery and analysis. Mol Cell 43(6):867-879
189. Breaker RR (2012) Riboswitches and the RNA world. Cold Spring Harb Perspect Biol 4(2):pii: a003566
190. Wan Y, Kertesz M, Spitale RC, Segal E, Chang HY (2011) Understanding the transcriptome through RNA structure. Nat Rev Genet 12(9):641-655. doi:10.1038/nrg3049
191. Villemejane J, Mir LM (2009) Physical methods of nucleic acid transfer: general concepts and applications. Br J Pharmacol 157(2):207-219. doi:10.1111/j.1476-5381. 2009.00032.x